Nitric Oxide-Releasing Docetaxel Prodrug Nanoplatforms for Effective Cancer Therapy

[1]  Youyong Yuan,et al.  Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy. , 2022, ACS nano.

[2]  Faxue Li,et al.  Nitric oxide-releasing L-Tryptophan and L-Phenylalanine based Poly(ester urea)s electrospun composite mats as antibacterial and antibiofilm dressing for wound healing , 2022, Composites Part B: Engineering.

[3]  L. Qiu,et al.  Near infrared light triggered ternary synergistic cancer therapy via L-arginine-loaded nanovesicles with modification of PEGylated indocyanine green. , 2021, Acta biomaterialia.

[4]  R. Garg,et al.  Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers , 2021, Pharmaceutical development and technology.

[5]  J. Sun,et al.  Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer. , 2021, ACS applied materials & interfaces.

[6]  Mengya Zhong,et al.  Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing , 2021, Journal of Nanobiotechnology.

[7]  Manjyot Kaur Chug,et al.  Therapeutic Delivery of Nitric Oxide Utilizing Saccharide-Based Materials. , 2021, ACS applied materials & interfaces.

[8]  Jianxin Wang,et al.  Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy. , 2021, ACS applied materials & interfaces.

[9]  Haishi Qiao,et al.  Glucose Oxidase and L-Arginine Functionalized Black Phosphorus Nanosheets for Multimodal Targeted Therapy of Glioblastoma , 2021, Chemical Engineering Journal.

[10]  Faxue Li,et al.  Phenylalanine-based poly(ester urea)s composite films with nitric oxide-releasing capability for anti-biofilm and infected wound healing applications. , 2021, Journal of colloid and interface science.

[11]  Qian Xu,et al.  Endogenous NO-release Carbon Nanodots for Tumor-specific Gas Therapy. , 2021, Acta biomaterialia.

[12]  Jong Seung Kim,et al.  Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy , 2021, Nature Communications.

[13]  G. Cao,et al.  Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study , 2021, Cancer communications.

[14]  Bingjun Sun,et al.  Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies , 2021, Theranostics.

[15]  J. Stenvang,et al.  A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer , 2021, Frontiers in Oncology.

[16]  M. Dawoud.  Chitosan coated solid lipid nanoparticles as promising carriers for docetaxel , 2021, Journal of Drug Delivery Science and Technology.

[17]  Xing-jie Liang,et al.  Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair–inhibiting (HYDRI) nanomedicine , 2021, Science Advances.

[18]  Yanli Zhao,et al.  Preparation and in vitro evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorption. , 2021, European journal of medicinal chemistry.

[19]  X. An,et al.  Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial. , 2020, JAMA.

[20]  Ch Lai,et al.  Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects. , 2020, Journal of materials chemistry. B.

[21]  Fan Yang,et al.  Construction and anti-tumor activities of disulfide-linked docetaxel-dihydroartemisinin nanoconjugates. , 2020, Colloids and surfaces. B, Biointerfaces.

[22]  H. Yao,et al.  Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer , 2020, Nature Communications.

[23]  Doudou Huang,et al.  Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects. , 2020, Journal of materials chemistry. B.

[24]  Haishi Qiao,et al.  Functional Biodegradable Nitric Oxide Donor-Containing Polycarbonate-Based Micelles for Reduction-Triggered Drug Release and Overcoming Multidrug Resistance. , 2019, ACS macro letters.

[25]  Jinlin He,et al.  Efficient Click Synthesis of Protonize & Reduction-Sensitive Amphiphilic Small Molecule Prodrug Containing Camptothecin and Gemcitabine for Drug Self-Delivery System. , 2019, Molecular pharmaceutics.

[26]  D. Scherman,et al.  Hemocompatibility investigation and improvement of near-infrared persistent luminescent nanoparticle ZnGa2O4:Cr3+ by surface PEGylation , 2019, Journal of Materials Chemistry B.

[27]  Michael J. Morris,et al.  Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial , 2018, JAMA oncology.

[28]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[29]  Y. Luan,et al.  pH- and Enzyme-Sensitive IR820-Paclitaxel Conjugate Self-Assembled Nanovehicles for Near-Infrared Fluorescence Imaging-Guided Chemo-Photothermal Therapy. , 2018, ACS applied materials & interfaces.

[30]  Xiaomin Wang,et al.  NO prodrug-conjugated, self-assembled, pH-responsive and galactose receptor targeted nanoparticles for co-delivery of nitric oxide and doxorubicin. , 2018, Nanoscale.

[31]  Yuejun Kang,et al.  Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics. , 2017, Biomaterials science.

[32]  Boguang Yang,et al.  Zwitterionic-Modified Starch-Based Stealth Micelles for Prolonging Circulation Time and Reducing Macrophage Response. , 2016, ACS applied materials & interfaces.

[33]  Ben Readhead,et al.  A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer. , 2015, Cancer cell.

[34]  Kanika Thakur,et al.  Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies. , 2014, International journal of biological macromolecules.

[35]  Jianbin Tang,et al.  Tumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy , 2013, Advanced materials.

[36]  C. Boyer,et al.  Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. , 2013, Chemical communications.

[37]  J. Schellens,et al.  Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). , 2011, International journal of pharmaceutics.

[38]  Maohong Fan,et al.  Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. , 2010, Journal of the American Chemical Society.

[39]  U. Kompella,et al.  Luteinizing hormone-releasing hormone receptor–targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy , 2009, Molecular Cancer Therapeutics.

[40]  E. Miele,et al.  Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer , 2009, International journal of nanomedicine.